| Independent Reports (Showing 1 to 10 of 18) |
Release Date ![[down]](http://us.i1.yimg.com/us.yimg.com/i/fi/down.gif) |
Contributor |
Author |
Title |
Pages |
Price |
More Info |
| 20-May-13 | Market Edge | N/A | Market Edge Equity Research Report | 4 | $10 | View Abstract |
| 18-May-13 | Pechala's Reports | Frantisek Pechala | PHARMACYCLICS INC (PCYC) 12-months forecast | 1 | $15 | View Abstract |
| 17-May-13 | New Constructs, LLC | N/A | PCYC: Due Diligence Review: Forensic Earnings and Valuation | 13 | $25 | View Abstract |
| 17-May-13 | ValuEngine, Inc. | N/A | ValuEngine Industry Report for Medical-drugs | 18 | $207 | View Abstract |
| 17-May-13 | Ford Investor Services, Inc. | N/A | Industry Value Graph: ASTX , AVEO , CPIX , PCYC , POZN -- DRUGS | 3 | $34.50 | View Abstract |
| 17-May-13 | Ford Investor Services, Inc. | N/A | Value Graph: PHARMACYCLICS -- PCYC | 1 | $11.50 | View Abstract |
| 16-May-13 | ValuEngine, Inc. | N/A | ValuEngine Detailed Valuation Report for PCYC | 11 | $126.50 | View Abstract |
| 14-May-13 | S&P Capital IQ Quantitative Report | N/A | Pharmacyclics Inc | 6 | $69 | View Abstract |
| 14-May-13 | Wright Reports | N/A | Wright Investors Service Comprehensive Report for Pharmacyclics, Inc. | 39 | $448.50 | View Abstract |
| 13-May-13 | Alpha Street Research | Hunter Orr | PCYC - Pharmacyclics Inc - Downgraded to a Sell - Company Analysis and ASR Ranking Report | 9 | $24 | View Abstract |